Treatment With Decitabine Increases Intracellular Reactive Oxygen Species Level by Reducing Glutathione Level and Glutathione Peroxidase 4 Activity in Myelodysplastic Syndrome Cells. The gene discussed is GPX4; the disease is myelodysplastic syndrome.